RYR1 and Malignant hyperthermia: Malignant hyperthermia (MH) is a very rare disease, in which symptoms are induced by a pharmacogenomic reaction, caused by genetic mutations in the ryanodine receptor 1 (RYR1) gene, which encodes a calcium channel protein.